Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.430
+0.020 (4.88%)
At close: Jun 26, 2026, 4:00 PM EDT
0.437
+0.007 (1.70%)
After-hours: Jun 26, 2026, 7:48 PM EDT
Heron Therapeutics Employees
Heron Therapeutics had 128 employees as of December 31, 2025. The number of employees increased by 6 or 4.92% compared to the previous year.
Employees
128
Change (1Y)
6
Growth (1Y)
4.92%
Revenue / Employee
$1,177,438
Profits / Employee
-$241,727
Market Cap
81.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| MindWalk Holdings | 102 |
| Cardiff Oncology | 31 |
| Entera Bio | 22 |
| iBio, Inc. | 20 |
| Rallybio | 14 |
| MAIA Biotechnology | 13 |
| Alterity Therapeutics | 9 |
HRTX News
- 17 days ago - Heron Therapeutics Transcript: AGM 2026 - Transcripts
- 25 days ago - Heron Therapeutics price target lowered to $2 from $4 at H.C. Wainwright - TheFly
- 25 days ago - Heron Therapeutics downgraded at Needham after Cinvanti patents invalidated - TheFly
- 25 days ago - Heron Therapeutics downgraded to Hold from Buy at Needham - TheFly
- 25 days ago - Heron announces U.S. district court decision regarding Cinvanti patents - TheFly
- 26 days ago - U.S. District Court Issues Decision Regarding CINVANTI® Patents - GlobeNewsWire
- 6 weeks ago - Heron Therapeutics price target lowered to $4 from $6 at H.C. Wainwright - TheFly
- 6 weeks ago - Heron Therapeutics reports Q1 EPS (4c), consensus (2c) - TheFly